News

Filter

Current filters:

MetabolicsXenical

US FDA warns of rare cases of liver injury with use of obesity drugs Xenical and Alli

27-05-2010

The US Food and Drug Administration yesterday advised consumers and health care professionals about potential…

AlliGlaxoSmithKlineMetabolicsNorth AmericaorlistatOrlistat 60 mgRegulationRocheXenical

Novo Nordisk’s diabetes jab Victoza "better than obesity drug at cutting weight"

26-10-2009

Participants in a double-blind, placebo-controlled 20-week trial with Danish drugmaker Novo Nordisk’s…

DiabetesEuropeHumulin 70-30Humulin NHumulin RInsulinMetabolicsNovo NordiskorlistatPharmaceuticalRocheXenical

UK’s MHRA won’t take action on Roche’s Xenical marketing

30-09-2009

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has decided not to pursue a…

EuropeMetabolicsorlistatPharmaceuticalRocheXenical

Rise in weight-loss drugs prescribed in the UK to combat childhood obesity

03-09-2009

Thousands of children and adolescents are using anti-obesity drugs that in the UK are only licensed for…

AlliEuropeGlaxoSmithKlineGSKMetabolicsorlistatOrlistat 60 mgPharmaceuticalRocheXenical

US FDA reviewing Roche weight loss drug Xenical and OTC alli from GlaxoSmithKline

25-08-2009

The US Food and Drug Administration says that it is reviewing adverse event reports of liver injury in…

AlliGlaxoSmithKlineGSKMetabolicsNorth AmericaorlistatOrlistat 60 mgPharmaceuticalRocheXenical

COMPANY SPOTLIGHT

Menarini

Back to top